1. Home
  2. HYFT

as of 10-09-2026 3:55pm EST

$1.50
+$0.07
+4.55%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Founded: 1983 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 63.1M IPO Year: 2017
Target Price: $4.33 AVG Volume (30 days): 323.6K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.99 - $3.00 Next Earning Date: 09-14-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 12.86% Revenue Growth (next year): 22.94%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: